Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap55.24B
Enterprise Value54.98B
P/E Ratio49.11
PEG Ratio6.88
Price/Sales Ratio7.03
Price/Book Ratio3.84
Enterprise/Revenue7.01
Enterprise/EBITDA33.03

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.14
Operating Margin0.11
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.08

Income Statement

Revenue4.31B
Revenue/Share4.23
Gross Profit3.13B
EBITDA1.11B
Net Income651.5M
Diluted EPS0.58

Balance Sheet

Total Cash2.31B
Total Cash/Share2.08
Total Debt864.75M
Total Debt/Equity0.1
Current Ratio2.03
Book Value Per Share7.82

Price History

52-Week Change-46.02
52-Week High70.99
52-Week Low29.25
Moving Average 50 Days31.31
Moving Average 200 Days41.55

Statistics

Average Volume17.16M
Shares Outstanding1.11B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.55
Trailing Annual Dividend Yield1.86
Payout Ratio0.83
Last Split Factor8:5
Last Split DateApril 24, 2015
AD